UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063636
Receipt number R000072799
Scientific Title Exploring routine work that contributes to improving executive function disorders
Date of disclosure of the study information 2026/11/15
Last modified on 2026/11/15 17:46:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Do posters at home help students who report ADHD traits keep submitting a daily to-do list?

Acronym

Posters and To-Do Lists Study

Scientific Title

Exploring routine work that contributes to improving executive function disorders

Scientific Title:Acronym

Environmental Cues and Executive Function Study

Region

Japan


Condition

Condition

Difficulties with everyday executive functioning associated with self-reported ADHD traits

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether displaying instruction sheets in five locations at home increases daily to-do list submission over 60 days compared with storing the sheets without displaying them, and to explore the association between submission rate and change in everyday executive functioning.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of days on which a to-do list was submitted via the study Google Form during the 60-day period (number of days with a submission / 60 x 100), calculated at the end of the 60-day period and compared between groups.

Key secondary outcomes

1. Change in executive function scores on the Japanese version of the BRIEF-A self-report form, measured before and after the 60-day period.
2. Association between to-do list submission rate and change in BRIEF-A scores (exploratory analysis).


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Intervention arm (with passive motivational cues): Five instruction sheets with a QR code are mailed to the participant and displayed in five visible locations at home. For 60 days, participants access a Google Form via the QR code at the start of each day and submit a to-do list containing the date and at least one task.

Interventions/Control_2

Control arm (without passive motivational cues): One instruction sheet with a QR code is mailed to the participant but is not displayed. For 60 days, participants submit a daily to-do list on their own initiative using the same Google Form as the intervention arm.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants who meet all of the following: (1) undergraduate or graduate students; (2) reported that at least one of the ADHD-related characteristics (difficulties in executive functioning) listed in the recruitment poster applies to them; (3) fully understood the purpose and procedures of the study and voluntarily consented to participate.

Key exclusion criteria

Participants who meet any of the following: (1) currently taking ADHD medication (e.g., Concerta, Strattera, Intuniv); (2) difficulty accessing the Google Form daily due to lack of a device or internet access; (3) diagnosed with and currently being treated for a serious psychiatric disorder (e.g., severe depression, bipolar disorder, schizophrenia) for which participation may pose a physical or psychological burden; (4) otherwise judged inappropriate by the principal investigator.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Ryosuke
Middle name
Last name Ohniwa

Organization

University of Tsukuba

Division name

Department of Educational Promotion

Zip code

305-8575

Address

Room 602, Bldg E, Medical Area, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan

TEL

029-853-3005

Email

ohniwa@ohniwa-lab.org


Public contact

Name of contact person

1st name Ryosuke
Middle name
Last name Ohniwa

Organization

University of Tsukuba

Division name

Department of Educational Promotion

Zip code

305-8575

Address

Room 602, Bldg E, Medical Area, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan

TEL

029-853-3005

Homepage URL


Email

ohniwa@ohniwa-lab.org


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

University of Tsukuba

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Faculty of Medicine, University of Tsukuba

Address

University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

Tel

029-853-3022

Email

sien.ningenss@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学(茨城県)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

29

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow

Of 29 participants who consented and were enrolled, 7 did not proceed to randomization. Of the 22 randomized (11 per arm), 3 in the control arm did not start the 60-day period. The remaining 19 participants (11 intervention, 8 control) started the intervention and were included in the analysis.

Adverse events

No adverse events were reported during the study period.

Outcome measures


Plan to share IPD

No

IPD sharing Plan description

In accordance with the study protocol, individual participant data will be used only for this study and will not be shared with other institutions.


Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2026 Year 04 Month 23 Day

Date of IRB

2026 Year 05 Month 07 Day

Anticipated trial start date

2026 Year 05 Month 14 Day

Last follow-up date

2026 Year 11 Month 22 Day

Date of closure to data entry

2026 Year 11 Month 26 Day

Date trial data considered complete

2026 Year 11 Month 26 Day

Date analysis concluded

2026 Year 11 Month 27 Day


Other

Other related information



Management information

Registered date

2026 Year 11 Month 15 Day

Last modified on

2026 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072799